Arax Advisory Partners’s Aspen Aerogels ASPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$293K Buy
+46,153
New +$226K ﹤0.01% 1986
2025
Q4
Sell
-10,324
Closed -$71.9K 4102
2025
Q3
$71.9K Buy
10,324
+8,601
+499% +$60.6K ﹤0.01% 1673
2025
Q2
$10.2K Buy
+1,723
New +$9.91K ﹤0.01% 1955
2024
Q3
Sell
-267
Closed -$6.37K 2623
2024
Q2
$6.37K Buy
+267
New +$6.27K ﹤0.01% 1483

Other funds holding ASPN

Arax Advisory Partners's ASPN Position: Q2 2026 in Review

Arax Advisory Partners opened a new position in Aspen Aerogels (ASPN) in Q2 2026: 46,153 shares worth $293K. The stake represents ﹤0.01% of the portfolio and ranks #1986 among its holdings. This is a return to the name: Arax Advisory Partners previously reported a position in ASPN as recently as Q3 2025.

Arax Advisory Partners first reported a position in ASPN in Q2 2024 and has held it in 4 quarters since. 180 funds tracked by Wall St. Rank hold ASPN as of Q2 2026.

  • Arax Advisory Partners held 46,153 shares of Aspen Aerogels worth $293K as of Q2 2026.
  • Aspen Aerogels was a new Arax Advisory Partners position in Q2 2026.
  • Aspen Aerogels made up ﹤0.01% of Arax Advisory Partners's portfolio in Q2 2026, its #1986 holding.
  • Arax Advisory Partners first reported a position in Aspen Aerogels in Q2 2024 and has held it in 4 quarters since.
  • 180 funds tracked by Wall St. Rank held Aspen Aerogels as of Q2 2026.

Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.